¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29
±³À°ÀÏÀÚ : 2022-01-29
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ÇѶó  
±³À°ÁÖÁ¦ : Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : meetings@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50000¿ø ÀüÀÓÀÇ 30000 ¿ø ±âŸ 70000¿ø ´çÀϵî·Ï : Àü¹®ÀÇ 60000¿ø ÀüÀÓÀÇ 40000 ¿ø ±âŸ 80000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-29 ÇѶó 09:00~09:25 Discoveries in metastasis biology and tumor microenvironment  ÀÌ´ë¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:25~09:50 Immune landscape in breast cancer  ±è¹Îȯ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:50~10:15 Dynamic ctDNA and genomic profiles to monitor response prediction  ÀÌÁöÀº(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 10:15~10:30 Q & A  () 
È޽Ġ01-29 ÇѶó 10:30~10:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 10:45~11:10 AI applied to imaging and biopsy  TBD(TBD) 
±³À°½Ã°£ 01-29 ÇѶó 11:10~11:35 Optimal loco-regional surgical management : Reducing the impact of axillary surgery  ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 11:35~12:00 Updates in Radiotherapy : Should one week of RT be standard of care?  ÀåÁö¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 12:00~12:25 Highlights of survivorship and lifestyle modification  °í¼öÁø(¿ï»êÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 12:25~12:40 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 12:40~13:10 TBD  ÀÓ¼®¾Æ(¼­¿ïÀÇ´ë) 
È޽Ġ01-29 ÇѶó 13:10~13:30 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 13:30~13:55 Optimal adjuvant endocrine treatment for HR+/HER2- EBC  ±èÇÑÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 13:55~14:20 Refining (neo)adjuvant immunotherapy and chemotherapy  ¹ÚÀÎÇý(°í·ÁÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 14:20~14:30 Q & A  () 
È޽Ġ01-29 ÇѶó 14:30~14:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 14:45~15:10 Advanced in systemic treatment options for HER2+ ABC  ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-29 ÇѶó 15:10~15:35 Novel SERDs, CDK inhibitors and beyond in advanced HR+/HER- ABC  ±èÁöÇü(¿¬¼¼ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 15:35~15:45 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 15:45~16:10 Therapeutic advances and new directions for TNBC  ¹Ú°æÈ­(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 16:10~16:35 New agents on the horizon  ÀÌ°æÀº(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 16:35~16:45 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ÀÚ·áºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥(2Â÷)(1ÀÏÂ÷) : 2022-02-04
´ÙÀ½±Û ´ëÇÑÇǺΰúÇÐȸ ºÎ»ê¿ï»ê°æ³² ÁöºÎȸ : 2022-01-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20222 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Æó°æÈ£¸£¸óÀÇ »îÀÇ Áú, È£¸£¸óÀÇ ¿ªÇÒ) : 2024-04-02 0 58 2024-04-01
20221 °æ±â ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ ¿ëÀÎÁö¿ª Çмú´ëȸ : 2024-04-28 0 147 2024-03-26
20220 ¼­¿ï (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28 0 19,547 2024-03-26
20219 ¼­¿ï 2024³â ´ëÇÑÇ׳ëÈ­ÇÐȸ Á¦23ȸ Ãá°èÇмú´ëȸ : 2024-04-28 0 303 2024-03-26
20218 Àü³² 2024³â Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãá°èÇмú´ëȸ : 2024-04-27 0 118 2024-03-26
20217 °­¿ø 2024³â ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °­¿øÁöȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-27 0 146 2024-03-26
20216 °æ±â 2024³â ´ëÇѽºÆ÷Ã÷°úÇС¤¿îµ¿ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-27 0 136 2024-03-26
20215 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ (¿Â¶óÀÎ) The 18th Basic Critical Care Review Course (BCCRC) : 2024-04-27 0 143 2024-03-26
20214 °æ±â ´ëÇѵΰæºÎ¿Ü°úÇÐȸ 2024 Ãá°è µÎ°æºÎ ÇÕµ¿¿¬¼öȸ : 2024-04-27 0 176 2024-03-26
20213 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(2ÀÏÂ÷) : 2024-04-26 0 118 2024-03-26
20212 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¸¸¼ººñºÎºñµ¿¿°) : 2024-04-26 0 110 2024-03-26
20211 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ(Biomechanics in Glaucoma) : 2024-04-26 0 83 2024-03-26
20210 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 509ȸ ÇмúÁý´ãȸ : 2024-04-25 0 86 2024-03-26
20209 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(1ÀÏÂ÷) : 2024-04-25 0 132 2024-03-26
20208 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ÀÇ ¿¹¹æÁ¢Á¾ Àü·«°ú ³ëÇÏ¿ì: HPV ¹é½ÅÀ» Áß½ÉÀ¸·Î : 2024-04-25 0 123 2024-03-26
61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷